SHU 508
Alternative Names: Echoscope; Levovist; SHTA 508; SHU/TA 508Latest Information Update: 02 Apr 2015
At a glance
- Originator Bayer Schering Pharma
- Class Contrast media; Polysaccharides
- Mechanism of Action Ultrasonography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Left ventricular dysfunction
Most Recent Events
- 01 Mar 2011 Bayer Schering Pharma is now called Bayer HealthCare Pharmaceuticals
- 01 Oct 2007 Mitsubishi Pharma Corporation has merged with Tanabe Seiyaku to form Mitsubishi Tanabe Pharma Corporation
- 29 Dec 2006 Schering AG is now called Bayer Schering Pharma AG